Alignment Healthcare (NASDAQ:ALHC) Insider Hyong Kim Sells 33,655 Shares

Key Points

• Hyong Kim, an insider at Alignment Healthcare, sold 33,655 shares on October 8th for approximately $581,895, which decreased his ownership by 7.52%.
• Alignment Healthcare's stock is currently trading at $17.19, reflecting a 2.0% decline during mid-day trading and holding a twelve-month financial range between $10.11 and $21.06.
• Analysts have mixed ratings on the stock, with two rating it a Strong Buy and one giving it a Sell, resulting in an average consensus rating of Moderate Buy and a price target of $18.83.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Hyong Kim sold 33,655 shares of the business's stock in a transaction that occurred on Wednesday, October 8th. The shares were sold at an average price of $17.29, for a total value of $581,894.95. Following the transaction, the insider directly owned 413,712 shares in the company, valued at approximately $7,153,080.48. This represents a 7.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Hyong Kim also recently made the following trade(s):

• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.57, for a total value of $902,729.03.
• On Friday, August 22nd, Hyong Kim sold 24,800 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.00, for a total value of $396,800.00.
• On Monday, August 11th, Hyong Kim sold 18,600 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.54, for a total value of $270,444.00.

Alignment Healthcare Stock Down 2.0%

NASDAQ:ALHC traded down $0.36 during mid-day trading on Friday, hitting $17.19. 432,343 shares of the company's stock traded hands, compared to its average volume of 3,166,579. Alignment Healthcare, Inc. has a twelve month low of $10.11 and a twelve month high of $21.06. The company has a market capitalization of $3.40 billion, a P/E ratio of -61.58 and a beta of 1.18. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The company has a fifty day moving average of $15.97 and a 200 day moving average of $15.67.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. During the same period last year, the business earned ($0.13) earnings per share. Alignment Healthcare's quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ALHC shares. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective on the stock in a report on Monday, August 25th. Zacks Research raised Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 29th. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a research report on Wednesday. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $9.00 to $13.00 in a research report on Thursday, July 31st. Finally, Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Institutional Trading of Alignment Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of ALHC. Amalgamated Bank increased its holdings in Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares during the last quarter. Tidal Investments LLC lifted its position in shares of Alignment Healthcare by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock valued at $253,000 after acquiring an additional 852 shares during the last quarter. Ballentine Partners LLC lifted its position in shares of Alignment Healthcare by 8.6% during the 1st quarter. Ballentine Partners LLC now owns 11,674 shares of the company's stock valued at $217,000 after acquiring an additional 924 shares during the last quarter. MCF Advisors LLC raised its stake in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after purchasing an additional 1,011 shares during the period. Finally, Cresset Asset Management LLC raised its holdings in shares of Alignment Healthcare by 0.6% during the first quarter. Cresset Asset Management LLC now owns 287,565 shares of the company's stock worth $5,354,000 after acquiring an additional 1,797 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.